News and publishing service for psychedelic related companies
Contact us:
512.354.7000
twitter
facebook
linkedin
News and publishing service for psychedelic related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
PNW Headlines
NRx Pharmaceuticals Inc. (NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
NRx Pharmaceuticals Inc. (NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
NRx Pharmaceuticals Inc. (NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies
NRx Pharmaceuticals Inc. (NRXP) Gains FDA Nod for Preservative-Free Ketamine Suitability Petition
NRx Pharmaceuticals Inc. (NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
Home
ยป
Market Research
PsychedelicNewsWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
512.354.7000
